Health Canada Approves Stoboclo, Osenvelt Biosimilars to Prolia, Xgeva

Read More »

September 19, 2025

EU Approves Henlius, Organon Biosimilars to PROLIA, XGEVA

Read More »

September 19, 2025

ForCast and KORU Partner on New Antibiotic Infusion Therapy

Read More »

September 18, 2025

SAPHNELO TULIP-SC Phase III Trial Hits Primary Endpoint

Read More »

September 17, 2025

Tinostamustine Added to GBM AGILE Trial for Glioblastoma

Read More »

September 17, 2025

RazorMetrics Saves Texans $34 Million on Prescriptions in 2 years

Read More »

September 17, 2025

SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

Read More »

September 16, 2025

Tandem Study: Type 2 Diabetes Patients Benefit from AID

Read More »

September 16, 2025

Hercules Pharmaceuticals Appoints Elie Bahou as Executive Vice President

Read More »

September 15, 2025

Raludotatug Deruxtecan Gets FDA Breakthrough for Ovarian Cancer

Read More »

September 15, 2025

Cocrystal Highlights CDI-988 Oral Antiviral for Norovirus Infection

Read More »

September 12, 2025

ENHERTU EU Approval for HER2+ Metastatic Tumor Variation

Read More »

September 11, 2025